Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/23/2867557/18623/en/Lisata-Therapeutics-and-Qilu-Pharmaceutical-Announce-First-Patient-Treated-in-Qilu-s-Phase-2-Trial-in-China-of-LSTA1-in-Patients-with-Metastatic-Pancreatic-Ductal-Adenocarcinoma.html
https://www.globenewswire.com/news-release/2024/04/09/2859986/18623/en/Lisata-Therapeutics-Announces-U-S-FDA-Orphan-Drug-Designation-Granted-to-LSTA1-for-the-Treatment-of-Osteosarcoma.html
https://www.globenewswire.com/news-release/2024/04/03/2856927/18623/en/Lisata-Therapeutics-to-Participate-in-Upcoming-April-2024-Industry-and-Investor-Events.html
https://www.pharmaceutical-technology.com/news/lisata-clinches-rare-disease-status-for-osteosarcoma-drug/
https://www.globenewswire.com/news-release/2024/03/21/2850166/18623/en/Lisata-Therapeutics-Announces-U-S-FDA-Rare-Pediatric-Disease-Designation-Granted-to-LSTA1-for-the-Treatment-of-Osteosarcoma.html
https://www.globenewswire.com//news-release/2024/02/29/2838385/18623/en/Lisata-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/22/2833625/18623/en/Lisata-Therapeutics-to-Host-Year-End-2023-Conference-Call-on-Thursday-February-29-2024-at-4-30-p-m-Eastern-Time.html
https://www.globenewswire.com//news-release/2024/02/20/2831757/18623/en/Lisata-Therapeutics-to-Present-at-BIO-CEO-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/01/18/2811546/0/en/Lisata-Therapeutics-to-Present-at-the-Sequire-Investor-Summit-in-Puerto-Rico.html
https://www.globenewswire.com//news-release/2024/01/17/2810664/18623/en/Lisata-Therapeutics-Announces-First-Patient-Treated-in-the-Phase-2a-Trial-of-LSTA1-in-Patients-with-Glioblastoma-Multiforme.html